Our research
Stem cells sustain tissue function via self-renewal and progressive differentiation into increasingly fate-restricted progenitor, precursor and mature cell types. We are interested in the dynamics of division and differentiation of stem and progenitor cells in human and how they become subverted in diseases such as cancer and as we age. Leveraging mathematical modelling and bioinformatic analysis of primary human tissue with functional experiments in vitro and in vivo, we aim to comprehensively understand how the dynamics and molecular regulation of these fundamental biological processes. To this end, we collaborate closely with clinical and experimental partners. Our research chiefly aims to address the following questions:
- How fast do human stem and progenitor cells divide and differentiate?
- When in life do tissues malignantly transform and how fast do malignant clones expand?
- How are normal and malignant division and differentiation decisions molecularly regulated?
Our research uses the continuous accumulation of somatic variants as molecular barcodes. We combine next generation sequencing at bulk and single cell resolution with the development of novel mathematical models of division and differentiation dynamics along stem and progenitor cell hierarchies. These models use fundamental principles from population genetics to identify characteristic footprints of genetic drift and clonal selection in the cumulative distribution of somatic variant allele frequencies (Figure 1). We use these tools to quantify tissue renewal in the aging human blood (Körber et al., Nature Genetics, 2025), and during the development of leukemia, brain cancer (Körber et al., Cancer Cell, 2019; Okonechnikov, Joshi & Körber et al., Nature, 2025) and neuroblastoma (Körber et al., Nature Genetics, 2023). In a complementary line of research, we generate single-cell multiome data from primary human tissue to generate mechanistic hypotheses on the molecular regulation of division and differentiation decisions in health and disease. We test these hypotheses experimentally in appropriate in vitro and in vivo models. Our research is driven by interdisciplinary teams with expertise in biology, medicine, mathematics, physics and data science.
